Benefit of intensity modulated and image-guided radiotherapy in prostate cancer;Apports de la radiothérapie avec modulation d'intensité guidée par l'image dans les cancers prostatiques

Cancer/Radiotherapie

Volumn 14, Issue 6-7, 2010, Pages 479-487

  Latorzeff, I ^a   Mazurier, J ^a   Boutry, C ^b   Dudouet, P ^b   Richaud, P ^c   de Crevoisier, R ^d  

^a CLINIQUE PASTEUR   (France)

^b Clinique du Pont de Chaume   (France)

^c INSTITUT BERGONIÉ   (France)

^d CENTRE EUGÈNE MARQUIS   (France)

Author keywords

Image guided radiotherapy; Intensity modulated radiotherapy; Prostate cancer

Indexed keywords

CANCER LOCALIZATION; CANCER PATIENT; DOSIMETRY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT OUTCOME; ADENOCARCINOMA; ARTIFACT; BLADDER; COMPUTER ASSISTED RADIOTHERAPY; MALE; METHODOLOGY; MOTION; MULTICENTER STUDY; PROSTATE; PROSTATE TUMOR; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; RECTUM; REVIEW; THREE DIMENSIONAL IMAGING;

ADENOCARCINOMA; ARTIFACTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MOTION; MULTICENTER STUDIES AS TOPIC; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTUM; TREATMENT OUTCOME; URINARY BLADDER;

EID: 77958190194     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.06.013     Document Type: Short Survey

References (52)

1. Al-Mamgani A., Heemsbergen W.D., Peeters S.T., Lebesque J.V. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 2009, 73:685-691.
2. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., van Leenders G.J., Slot A., Dielwart M.F., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72:980-988.
3. Artignan X., Rastkhah M., Balosso J., Fourneret P., Gilliot O., Bolla M. Quantification des mouvements prostatiques lors de l'irradiation prostatique. Cancer Radiother 2006, 10:381-387.
4. Ashman J.B., Zelefsky M.J., Hunt M.S., Leibel S.A., Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:765-771.
5. Azria D., Aillères N., Llacer Moscardo C., Hay M.H., Dubois J.B., Fenoglietto P. Radiothérapie de conformation avec modulation d'intensité dans le cancer de prostate: vers un nouveau standard. Cancer Radiother 2009, 13:409-415.
6. Beckendorf V., Guérif S., Le Prisé é., Cosset J.M., Lefloch O., Chauvet B., et al. The GETUG 70Gy vs 80Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 2004, 60:1056-1065.
7. Cahlon O., Hunt M., Zelefsky M.J. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol 2008, 18:48-57.
8. Cahlon O., Zelefsky M.J., Shippy A., Chan H., Fuks Z., Yamada Y., et al. Ultra-high dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 2008, 71:330-337.
9. Cazoulat G., de Crevoisier R., Simon A., Louvel G., Manens J.P., Lafond C., et al. Bénéfice volumétrique de la radiothérapie guidée par l'image dans les cancers prostatiques: marges et cartographies de probabilité de présence. Cancer Radiother 2009, 13:365-374.
10. Chauvet B., Oozeer R., Bey P., Pontvert D., Bolla M. Radiothérapie conformationnelle des cancers de la prostate: revue générale. Cancer Radiother 1999, 3:393-406.
11. Chung H.T., Xia P., Chan L.W., Park-Somers E., Roach M. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 2009, 73:53-60.
12. De Crevoisier R., Pommier P., Bachaud J., Créhange G., Boutry C., Chauvet B., et al. Image-guided radiation therapy (IGRT) in prostate cancer: preliminary results in prostate registration and acute toxicity of a randomized study. Int J Radiat Oncol Biol Phys 2009, 75:S99.
13. de Crevoisier R., Tucker S.L., Dong L., Mohan R., Cheung R., Cox J.D., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:965-973.
14. De Meerleer G.O., Fonteyne V.H., Vakaet L., Villeirs G.M., Denoyette L., Verbaeys A., et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 2007, 82:160-166.
15. Dearnaley D.P., Khoo V.S., Norman A.R., Meyer L., Nahum A., Tait D., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999, 353:267-272.
16. Dearnaley D.P., Sydes M.R., Langley R.E., Graham J.D., Huddart R.A., Syndikus I., et al. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol 2007, 83:31-41.
17. Delpon G., Llagostera C., Le Blanc M., Rio E., Supiot S., Mahé M.A., et al. Quelle radiotherapie guidée par l'image pour quels patients ? Experience concomitante de l'utilisation de trois dispositifs d'imagerie de repositionnement dans le cas du cancer de la prostate. Cancer Radiother 2009, 13:399-407.
18. Dudouet P., Boutry C., Mounie G., Latorzeff I., Thouveny F., Redon A. Système d'imagerie par tomographie conique de basse énergie (kV)de Varian: expérience de Montauban. Cancer Radiother 2009, 13:375-383.
19. Fenoglietto P., Laliberte B., Allaw A., Ailleres N., Idri K., Hay M.H., et al. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiother Oncol 2008, 88:77-87.
20. Fiorino C., Di Muzio N., Broggi S., Cozzarini C., Maggiulli E., Alongi F., et al. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 2008, 71:611-617.
21. Fonteyne V., Villeirs G., Lumen N., De Meerleer G. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol 2009, 92:42-47.
22. Gulliford S.L., Foo K., Morgan R.C., Aird E.G., Bidmead A.M., Critchley H., et al. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys 2010, 76:747-754.
23. Heemsbergen W.D., Hoogeman M.S., Witte M.G., Peeters S.T., Incrocci L., Lebesque J.V. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68Gy versus 78Gy. Int J Radiat Oncol Biol Phys 2007, 67:1418-1424.
24. Isambert A., Ferreira I.H., Bossi A., Beaudre A., Nicula L.E., Lefkopoulos D. Dose delivree au patient lors de l'acquisition d'images par tomographie conique de haute energie. Cancer Radiother 2009, 13:358-364.
25. Jacob R., Hanlon A.L., Horwitz E.M., Movsas B., Uzzo R.G., Pollack A. The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer 2004, 100:538-543.
26. Jouyaux F., Lafond C., Bellec J., Cazoulat C., Louvel G., Le Prisé E., et al. Irradiation de la prostate avec modulation d'intensité: du step & shoot au VMAT. Cancer Radiother 2009, 13:670-671.
27. Kjaer-Kristoffersen F., Ohlhues L., Medin J., Korreman S. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009, 48:227-232.
28. Kuban D.A., Tucker S.L., Dong L., Starkschall G., Huang E.H., Cheung M.R., et al. Long-term results of the MD. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
29. Lefkopoulos D., Isambert A., de Crevoisier R. Expérience française sur la radiothérapie guidée par l'image: contrôle de qualité, dose additionnelle délivrée, protocoles de radiothérapie guidée par l'image et premières données cliniques. Cancer Radiother 2009, 13:341-344.
30. Luo C., Yang C.C., Narayan S., Stern R.L., Perks J., Goldberg Z., et al. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66:1253-1262.
31. Marinello G., Mège J.P., Besse M.C., Kerneur G., Lagrange J.L. Radiothérapie des cancers de la prostate: évaluation in vivo de la dose délivrée par tomographie conique de basse énergie (kV). Cancer Radiother 2009, 13:353-357.
32. Melancon A.D., O'Daniel J.C., Zhang L., Kudchadker R.J., Kuban D.A., Lee A.K., et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol 2007, 85:251-259.
33. Morgan P., Ruth K., Horwitz E.M., Buyyounouski M.K., Uzzo R.G., Pollack A. A matched pair comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy for prostate cancer: toxicity and outcomes. Int J Radiat Oncol Biol Phys 2007, 69:S319.
34. Naudy S., Peignaux K., Brenier J.P., Créhange G., Arnaud A., Truc G., et al. Mise en oeuvre de la radiothérapie conformationnelle par modulation d'intensité guidée par échographie transabdominale. Cancer Radiother 2006, 10:388-393.
35. Palma D., Vollans E., James K., Nakano S., Moiseenko V., Shaffer R., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:996-1001.
36. Peeters S.T., Heemsbergen W.D., Koper P.C., van Putten W.L., Slot A., Dielwart M.F., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68Gy of radiotherapy with 78Gy. J Clin Oncol 2006, 24:1990-1996.
37. Pommier P., Morelle M., Remonnay R., de Crevoisier R. évaluation économique prospective de la radiothérapie guidée par l'image (IGRT) appliquée aux cancers de la prostate. Résultats Préliminaires de l'étude " programme de Soutien aux techniques innovantes coûteuses (Stic). Cancer Radiother 2009, 13:634-643.
38. Shipley W.U., Verhey L.J., Munzenrider J.E., Suit H.D., Urie M.M., McManus P.L., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995, 32:3-12.
39. Steenbakkers R.J., Deurloo K.E., Nowak P.J., Lebesque J.V., van Herk M., Rasch C.R. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 2003, 57:1269-1279.
40. Symon Z., Griffith K.A., McLaughlin P.W., Sullivan M., Sandler H.M. Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 2003, 57:384-390.
41. Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP. Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 Trial (Isrctn47772397). Int J Radiat Oncol Biol Phys 2010;1:773-83.
42. Valette P.J., Cotton F., Giammarile F. La délimitation des volumes cibles en radiothérapie: application des techniques d'imagerie. Cancer Radiother 2009, 13:581-587.
43. Vora S.A., Wong W.W., Schild S.E., Ezzell G.A., Halyard M.Y. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68:1053-1058.
44. Wolff D., Stieler F., Welzel G., Lorenz F., Abo-Madyan Y., Mai S., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009, 93:226-233.
45. Zelefsky M.J., Chan H., Hunt M., Yamada Y., Shippy A.M., Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006, 176:1415-1419.
46. Zelefsky M.J., Fuks Z., Happersett L., Lee H.J., Ling C.C., Burman C.M., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000, 55:241-249.
47. Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881.
48. Zelefsky M.J., Fuks Z., Hunt M., Yamada Y., Marion C., Ling C.C., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53:1111-1116.
49. Zelefsky M.J., Yamada Y., Fuks Z., Zhang Z., Hunt M., Cahlon O., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71:1028-1033.
50. Zelefsky M.J., Yamada Y., Kollmeier M.A., Shippy A.M., Nedelka M.A. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer. Eur Urol 2008, 53:1172-1179.
51. Zhang P., Happersett L., Hunt M., Jackson A., Zelefsky M., Mageras G. Volumetric modulated Arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 2010, 76:1456-1462.
52. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi C.J., Miller D.W., Adams J.A., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005, 294:1233-1239.